RFC3作为一种新的预后生物标志物和头部和部状细胞癌的标

Keerthana Reddy Avs1, Chandra Pandi2, Balachander Kannan2

  • 1Saveetha Medical College and Hospitals, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai, India.

PubMed
概括

复制因子C子单元3 (RFC3) 在头部和部状细胞癌 (HNSCC) 中被上调. 高RFC3表达表明预后不佳,并可能成为HNSCC患者的治疗点.